Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A progressive fine-tuning strategy for domain-specific large language models in wastewater treatment plants safety.

Scientific reports·2026
Same author

Spinless and Spinful Charge Excitations in Moiré Fractional Chern Insulators.

Physical review letters·2026
Same author

Excitatory neurons and astrocytes-specific dysregulation and aberrant interactions are vulnerable to FCDI as suggested by single-cell spatial transcriptomics.

Clinical and translational medicine·2026
Same author

CACNA1A c.5610del in a three-generation family: epilepsy with ataxia/migraine.

BMC neurology·2026
Same author

Strength-ductility synergy in medium-entropy alloys via harnessing trace air in additive manufacturing.

Nature communications·2026
Same author

Stoichiometric FeTe is a superconductor.

Nature·2026

Related Experiment Video

Updated: Jul 3, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Epilepsy: Epidemiology, Molecular Pathogenesis, and Clinical Management.

Jian Liu1,2, Xinyan Wu1,2, Ting Yin1,2

  • 1School of Pharmaceutical Sciences Guangzhou University of Chinese Medicine Guangzhou China.

Medcomm
|July 2, 2026
PubMed
Summary

Epilepsy treatment faces challenges with drug-resistant cases. Understanding epileptogenesis mechanisms is key to developing personalized, disease-modifying therapies beyond seizure suppression.

Keywords:
clinical managementepidemiologyepilepsymechanism

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Area of Science:

  • Neurology
  • Neuroscience
  • Epilepsy Research

Background:

  • Epilepsy is a prevalent neurological disorder with significant global impact.
  • A substantial portion of patients (nearly one-third) exhibit resistance to current antiseizure medications.
  • Gaps persist in understanding the fundamental processes of epileptogenesis and epilepsy progression.

Purpose of the Study:

  • To review epidemiological data, seizure patterns, and pathogenic mechanisms underlying epilepsy.
  • To explore how recent mechanistic insights are transforming clinical management strategies.
  • To highlight emerging therapeutic avenues and data-driven tools for personalized epilepsy care.

Main Methods:

  • Review of epidemiological evidence and time-dependent seizure patterns.
  • Analysis of pathogenic mechanisms including genetic, cellular, and network alterations.
  • Synthesis of current and emerging clinical management strategies and therapeutic approaches.

Main Results:

  • Identified converging pathogenic mechanisms (genetic, ion-channel, synaptic, inflammatory, metabolic, structural, network, epigenetic) that destabilize neural circuits.
  • Detailed the interaction of these processes across disease stages, leading to persistent hyperexcitability.
  • Summarized advancements in precision diagnostics, pharmacotherapy, surgery, neuromodulation, dietary interventions, chronotherapy, and novel disease-modifying treatments.

Conclusions:

  • Current evidence advocates a paradigm shift from empirical seizure suppression to mechanism-guided, individualized epilepsy care.
  • Future progress hinges on integrating molecular discoveries, validated biomarkers, and real-world implementation for earlier and potentially disease-modifying treatments.
  • Emphasizes the need for equitable access to advanced diagnostic and therapeutic strategies for all epilepsy patients.